In a maneuver that redefines the country’s geopolitical position, Argentina today formalized its withdrawal from the World Health Organization (WHO). The decision, although celebrated by the ruling party as an act of sovereignty, opens a complex scenario of doubts about the national health future.
The WHO Output It was finalized this Tuesday after the legal notice periods had been met. The Government maintains that this measure is the definitive response to what they consider a «failed and centralized» management of global public health, especially after the experience of the pandemic. However, the impact of leaving the governing body of the United Nations has aspects that directly affect both the State coffers and access to science.
The benefit explained by the government
From the Executive’s perspective, the main benefit of the WHO Output lies in the recovery of operational autonomy. By not being bound by international health treaties and regulations (IHR), Argentina is no longer obliged to follow global emergency protocols that, according to official discourse, «stifled the economy and individual freedoms» in previous years.
In addition, there is an immediate economic factor: the saving of the annual membership fee that the country had to pay in dollars. The Government plans to redirect these resources to strengthen internal epidemiological surveillance and strengthen bilateral agreements with nations that share its vision of «health freedom», avoiding international bureaucratic structures that they consider inefficient.
Isolation and loss of technical network
On the other hand, scientific criticism warns about the risks of this «isolation.» The most severe damage of the WHO Output It is the disconnection of early warning networks in the face of new epidemics. Argentina loses its seat at the table where the annual strains for the flu vaccine and priority access to genomic data banks shared by 194 countries are decided.
Likewise, although the link with the PAHO (Pan American Health Organization) is maintained, the departure of the parent entity could hinder the international approval of Argentine medicines and access to certain funding funds for research that require membership in the WHO. Uncertainty now revolves around whether the local health system is robust enough to self-manage in the face of a crisis of global magnitude.
Towards a new health model?
With this step, Argentina becomes a case study for the rest of the world. While the ruling party assures that it is the end of the «international health dictatorship», opposition sectors and academics fear that the country has been left unprotected against the biological threats of the 21st century. The coin is in the air and the real impact will be felt when the next major health challenge emerges.
